J. Balser

发表

Intravaginal dehydroepiandrosterone (prasterone), a highly efficient treatment of dyspareunia

C. Labrie, F. Labrie, C. Martel, 2011, Climacteric : the journal of the International Menopause Society.

Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy

C. Labrie, F. Labrie, C. Martel, 2009, Menopause.

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

F. Labrie, C. Martel, D. Archer, 2015, Menopause.

Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12weeks

F. Labrie, C. Martel, D. Archer, 2016, The Journal of Steroid Biochemistry and Molecular Biology.

Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause

F. Labrie, C. Martel, D. Archer, 2016, Menopause.

Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women: role of the ovary?

F. Labrie, C. Martel, J. Balser, 2011, Menopause.

Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women.

C. Labrie, F. Labrie, C. Martel, 2014, The journal of sexual medicine.

Effect of intravaginal dehydroepiandrosterone (DHEA) on the female sexual function in postmenopausal women: ERC-230 open-label study

L. Derogatis, F. Labrie, C. Martel, 2016, Hormone molecular biology and clinical investigation.

Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration

F. Labrie, C. Martel, D. Archer, 2015, The Journal of Steroid Biochemistry and Molecular Biology.

Influence of treatment of vulvovaginal atrophy with intravaginal prasterone on the male partner

F. Labrie, C. Martel, D. Archer, 2015, Climacteric : the journal of the International Menopause Society.

The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.

D. Gaudet, D. Rader, R. Hegele, 2015, Atherosclerosis.

Intracrine formation from dehydroepiandrosterone versus ovarian secretion of testosterone

F. Labrie, C. Martel, J. Balser, 2011 .

Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration

C. Labrie, R. Bérubé, F. Labrie, 2009, Menopause.

Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women

C. Labrie, F. Labrie, C. Martel, 2009, Menopause.

Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy.

L. Derogatis, F. Labrie, C. Martel, 2015, The journal of sexual medicine.

Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study.

C. Labrie, F. Labrie, C. Martel, 2015, Maturitas.

Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)

C. Labrie, F. Labrie, C. Martel, 2015, Menopause.

Cardiac electrophysiologic effects of fentanyl and sufentanil in canine cardiac Purkinje fibers.

J. Blair, R. Adams, J. Balser, 1989, Anesthesiology.

Decreased efficacy of twice-weekly intravaginal dehydroepiandrosterone on vulvovaginal atrophy

C. Labrie, F. Labrie, C. Martel, 2015, Climacteric : the journal of the International Menopause Society.

High internal consistency and efficacy of intravaginal DHEA for vaginal atrophy

C. Labrie, F. Labrie, C. Martel, 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

The Metreleptin Effectiveness and Safety Registry (MEASuRE): concept, design and challenges

M. Haymond, C. Musso, J. von Schnurbein, 2023, Orphanet Journal of Rare Diseases.

Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator

F. Labrie, C. Martel, D. Archer, 2016, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy.

L. Derogatis, F. Labrie, C. Martel, 2015, The journal of sexual medicine.